drugset / Trial / NCT02235012
Cognitive Biases Under Ketamine
Completed
84 enrolled
Centre Hospitalier St Anne
Association Schizo Oui · collabComité pour la Recherche Hospitalière Médicale · collabFondation Fyssen · collabFondation pour la Recherche Médicale · collab
RandomizedCrossoverTriple-blindBasic science
Summary
Characterise cognitive biases resulting from low dose ketamine infusion, used as a pharmacological model of psychosis. Our assumption is that low dose ketamine results in reasoning biases by impairing the way uncertainty is monitored and taken into account for decision making.
Timeline
- Start
- 2014-09-08
- Primary completion
- 2022-04-28
- Completion
- 2022-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.00483 mg/kg | Other |
Indications
No indication recorded.